telehealth glp-1 crackdown news The FDA announced plans to take action against non-FDA-approved receptor agonists, a move that prompted company Hims & Hers to yank its new compounded semaglutide (Wegovy) weight-loss pill from the FDA Issues 30 Warning Letters
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13






























